SEARCH

SEARCH BY CITATION

References

  • 1
    Scheinman JI. Sickle cell disease and the kidney. Nat Clin Pract Nephrol 2009;5:7888.
  • 2
    Ataga KI, Orringer EP. Renal abnormalities in sickle cell disease. Am J Hematol 2000;63:205211.
  • 3
    Allon M, Lawson L, Eckman JR, et al. Effects of nonsteroidal antiinflammatory drugs on renal function in sickle cell anemia. Kidney Int 1988;34:500506.
  • 4
    Bank N, Aynedjian HS, Qiu J, et al. Renal nitric oxide synthases in transgenic sickle cell mice. Kidney Int 1996;50:184189.
  • 5
    Ware RE, Rees RC, Sarnaik SA, et al;BABY HUG Investigators. Renal function in infants with sickle cell anemia: Baseline data from the BABY HUG trial. J Pediatr 2010;156:6670.
  • 6
    Wigfall DR, Ware RE, Burchinal MR, et al. Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease. J Pediatr 2000;136:749753.
  • 7
    Aygun B, Mortier NA, Smeltzer MP, et al. Glomerular hyperfiltration and microalbuminuria in children with sickle cell anemia. Pediatr Nephrol 2011:2698:12851290.
  • 8
    Schmitt F, Martinez F, Brillet G, et al. Early glomerular dysfunction in patients with sickle cell anemia. Am J Kidney Dis 1998;32:208214.
  • 9
    Haymann JP, Stankovic K, Levy P, et al. Glomerular hyperfiltration in adult sickle cell anemia: A frequent hemolysis associated feature. Clin J Am Soc Nephrol 2010;5:756761.
  • 10
    Wang WC, Ware RE, Miller ST, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: A multicenter, randomized, controlled trial (BABY HUG). Lancet 2011;377:16631672.
  • 11
    Thornburg CD, Dixon N, Burgett S, et al. A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia. Pediatr Blood Cancer 2009;52:609615.
  • 12
    Lebensburger J, Johnson SM, Askenazi DJ, et al. Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia. Am J Hematol 2011;86:430432.
  • 13
    Fitzhugh CD, Wigfall DR, Ware RE. Enalapril and hydroxyurea therapy for children with sickle cell nephropathy. Pediatr Blood Cancer 2005;45:982985.
  • 14
    McKie KT, Hanevold CD, Hernandez C, et al. Prevalence, prevention and treatment of microlabuminuria and proteinuria inc children with sickle cell disease. J Pediatr Hematol Oncol 2007;29:140144.
  • 15
    Alvarez O, Montane B, Lopez G, et al. Early blood transfusions protect against microalbuminuria in children with sickle cell disease. Pediatr Blood Cancer 2006;47:7176.
  • 16
    Heeney MM, Ware RE. Hydroxyurea for children with sickle cell disease. Pediatr Clin North Am 2008;55:483501.
  • 17
    Zimmerman SA, Schultz WH, Davis JS, et al. Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood 2004;103:20392045.
  • 18
    Rodman JH, Maneval DC, Magill HL, Sunderland M. Measurement of Tc99 m DTPA serum clearance for estimating glomerular filtration rate in children with cancer. Pharmacotherapy 1993;13:1016.
  • 19
    Piepsz A, Tondeur M, Ham H. Revisiting normal (51) Cr-ethylenediaminetetraacetic acid clearance values in children. Eur J Nucl Med Mol Imaging 2006;12:14771482.
  • 20
    Pegelow CH, Colangelo L, Steinberg M, et al. Natural History of blood pressure in sickle cell disease: Risks for stroke and death are associated with relative hypertension in sickle cell anemia. Am J Med 1997;102:171177.
  • 21
    Charache S, Dover GJ, Moore RD, et al. Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia. Blood 1992;79:25552565.
  • 22
    Kinney TR, Helms RW, O'Branski EE, et al. Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood 1999;94:15501554.
  • 23
    Wang WC, Wynn LW, Rogers ZR, et al. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. J Pediatr 2001;139:790796.
  • 24
    Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332: 13171322.
  • 25
    Alvarez O, Miller ST, Wang WC, et al. Effect of hydroxyurea treatment on renal function parameters: Results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia. Pediatr Blood Cancer 2012;59:668674.